Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:49 PM
Ignite Modification Date:
2025-12-24 @ 7:49 PM
NCT ID:
NCT02054403
Eligibility Criteria:
Inclusion Criteria:
1. Caucasian race
2. 40-80 years
3. Willing and able to comply with scheduled visits and other study procedures
4. Signed informed consent
5. Participants derived from the study 'Caucasian patients with angle closure on SS-OCT' AND 1 or more of the following:
* Irido-trabecular contact (ITC) in ≥2 quadrants as seen with SS-OCT in darkened conditions
* Scleral spur angle (SSA) \<20˚ (in 0 and 180º) AND anterior chamber depth (ACD) \< 2.5 mm as seen with SS-OCT in darkened conditions
* The fellow, non-treated eye in a patient after an acute primary angle closure (APAC) attack in the other eye. APAC is defined as an abrupt onset of symptomatic elevation of IOP resulting from total closure of the angle which is typically not self-limiting (although acute attacks can rarely resolve spontaneously).
Exclusion Criteria:
1. Any condition including (previous) intraocular laser/incisional surgery or medical procedure or treatment in ophthalmology
2. Any eye condition/abnormality that will affect the acquisition/reliability of measurement (results), (e.g. vitreous haemorrhage, uveitis, intraocular trauma, significant corneal opacity)
3. Unable to communicate properly or to understand instructions
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
40 Years
Maximum Age:
80 Years
Study:
NCT02054403
Study Brief:
Protocol Section:
NCT02054403